Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Reporting results of cancer treatment
1981 • 7,916 citations
A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients
1998 • 777 citations
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
1994 • 584 citations
High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection
1995 • 306 citations
Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection
1996 • 293 citations
Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
2000 • 283 citations
Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical use
1996 • 132 citations
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase
1991 • 121 citations
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans
1993 • 104 citations
DRESS (Drug Rash with Eosinophilia and Systemic Syndrome Associated with Nevirapine Therapy
1998 • 94 citations
Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection
1998 • 80 citations
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients
1996 • 80 citations
High‐Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1‐Infected Persons Does Not Result in Sustained Suppression of Viral Replication
1997 • 68 citations
Cited By (0)
No citing papers found in database